Table of Contents

1. Report Overview
1.1 Global Neurovascular Devices Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecasting Methodology
1.7 Frequently Asked Questions (FAQ)

2. Introduction to Neurovascular Diseases
2.1 Overview
2.2 Stroke
2.2.1 Types of Strokes
2.2.1.1 Ischaemic stroke:
2.2.1.2 Haemorrhagic stroke:
2.3 Cerebral Artery Stenosis
2.3.1 Diagnosis
2.3.2 Treatment of Cerebral Artery Stenosis
2.3.2.1 Angioplasty
2.3.2.2 Cerebral artery bypass
2.4 Cerebral Aneurysm
2.4.1 Causes of Cerebral Aneurysm
2.4.2 Types of Aneurysms
2.4.3 Prevalence of Aneurysms
2.4.4 Diagnosis of Aneurysms
2.4.5 Treatment of Aneurysms
2.5 Arteriovenous Malformation and Fistulas
2.5.1 Types of AVMs
2.5.2 Epidemiology
2.5.3 Diagnosis of AVM
2.5.4 Treatment of AVMs

3. Global Neurovascular Devices Market Forecast to 2027
3.1 The Global Neurovascular Devices Market Forecast to 2027

4. Leading Neurovascular Devices Submarket Forecast to 2027
4.1 Devices Composition of the Global Market in 2016 and 2027
4.2 Leading Devices Markets for Neurovascular Devices Forecast to 2027
4.2.1 Cerebral Embolization and Aneurysm Coiling Devices
4.2.1.1 Cerebral Embolization and Aneurysm Coiling Devices Market Forecast to 2027
4.2.2 Cerebral Angioplasty and Stenting Systems
4.2.2.1 Cerebral Angioplasty and Stenting Systems Market Forecast to 2027
4.2.3 Support Devices
4.2.3.1 Support Devices Market Forecast to 2027
4.2.4 Neurothrombectomy Devices
4.2.4.1 Neurothrombectomy Devices Market Forecast to 2027

5. Neurovascular Devices: Leading Regional and National Market Forecast to 2027
5.1 Regional Composition of the Global Market in 2016 and 2027
5.3 Leading Regional and National Markets for Neurovascular Devices Market Forecast to 2027
5.3.1 US Neurovascular Devices Market Forecast to 2027
5.3.1.1 The US Will Dominate Throughout the Forecast Period
5.3.1.2 US Neurovascular Devices Market Forecast to 2027
5.3.2 EU5 Neurovascular Devices Market Forecast to 2027
5.3.2.1 German Neurovascular Devices Market: Leader in EU, but Facing Big Reforms
5.3.2.1.1 German Neurovascular Devices Market Forecast to 2027
5.3.2.2 French Neurovascular Devices Market: Strong National Healthcare System, Despite Economic Woes
5.3.2.2.1 French Neurovascular Devices Market Forecast to 2027
5.3.2.3 Italian Neurovascular Devices Market
5.3.2.3.1 Italian Neurovascular Devices Market Forecast to 2027
5.3.2.4 UK Neurovascular Devices Market: Pricing is a Key Issue, Providing Restraints to Revenues
5.3.2.4.1 UK Neurovascular Devices Market Forecast to 2027
5.3.2.5 Spanish Neurovascular Devices Market
5.3.2.5.1 Spanish Neurovascular Devices Market Forecast to 2027
5.3.3 Japanese Neurovascular Devices Market
5.3.3.1 Japanese Neurovascular Devices Market Forecast to 2027
5.3.4 BRIC Neurovascular Devices Market Forecast to 2027
5.3.4.1 China Neurovascular Devices Market: Rapid Growth Will Make it one of the Major Global Players
5.3.4.1.1 China Neurovascular Devices Market Forecast to 2027
5.3.4.2 Brazilian Neurovascular Devices Market: Taken Great Strides Forward with Healthcare
5.3.4.2.1 Brazilian Neurovascular Devices Market Forecast to 2027
5.3.4.3 Russian Neurovascular Devices Market: Punches Below its Weight
5.3.4.3.1 Russian Neurovascular Devices Market Forecast to 2027
5.3.4.4 Indian Neurovascular Devices Market
5.3.4.4.1 Indian Neurovascular Devices Market Forecast to 2027
5.3.5 Rest of the World (ROW)
5.3.5.1 ROW Neurovascular Devices Market Forecast, 2016-2027

6. SWOT Analysis of the Neurovascular Devices Market
6.1 Strengths
6.1.1 Aging Population
6.1.2 Rising Incidence of Obesity
6.1.3 High Incidence of Strokes
6.1.4 Increasing Demand for Minimally Invasive Procedures
6.1.5 Technological Advancements
6.2 Weakness
6.2.1 Disadvantages of Neurovascular Devices
6.3 Opportunities
6.3.1 Healthcare expenditures
6.4 Threats
6.4.1 High Cost of R&D Activities

7. Leading Companies
7.1 Stryker Corporation
7.1.1 Introduction
7.1.2 Recent Performance Analysis
7.1.3 Total Company Sales by Business Segments,2016
7.1.4 Stryker Products
7.2 Medtronic
7.2.1 Introduction
7.2.2 Recent Performance Analysis
7.2.3 Total Company Sales by Business Segments,2017
7.2.4 Medtronic Products
7.3 Johnson & Johnson
7.3.1 Introduction
7.3.2 Recent Performance Analysis
7.3.3 Total Company Sales by Business Segments,2016
7.3.4 Johnson & Johnson Products
7.4 Terumo
7.4.1 Introduction
7.4.2 Recent Performance Analysis
7.4.3 Total Company Sales by Business Segments,2016
7.4.4 Terumo Products
7.5 Penumbra
7.5.1 Introduction
7.5.2 Recent Performance Analysis
7.5.3 Total Company Sales by Business Segments,2016
7.5.4 Penumbra Products

8. Conclusion
8.1 Neurovascular Devices Market Forecast
8.2 The US has the Largest Share
8.3 Cerebral Embolization and Aneurysm Coiling Devices Dominates the Neurovascular Devices Market